Part of Cancer staging guidance sheets
Uterus - endometrium (ICD10 C54.1, C55)
Page contents
Stage groupings
FIGO Stage |
Description |
---|---|
Ia |
Tumour confined to the corpus uteri |
IAa |
No or less than half myometrial invasion |
IBa |
Invasion equal to or more than half of the myometrium |
IIa |
Tumour invades cervical stroma, but does not extend beyond the uterus b |
IIIa |
Local and/or regional spread of the tumour |
IIIAa |
Tumour invades the serosa of the corpus uteri and/or adnexae c |
IIIBa |
Vaginal involvement and/ or parametrial involvement c |
IIICa |
Metastases to pelvic and/or para-aortic lymph nodes c |
IIIC1a |
Positive pelvic nodes |
IIIC2a |
Positive para-aortic nodes with or without positive pelvic lymph nodes |
IVa |
Tumour invades bladder and/or bowel mucosa, and/or distant metastases |
IVAa |
Tumour invasion of bladder and/or bowel mucosa |
IVBa |
Distant metastasis, including intra-abdominal metastases and/or inguinal nodes) |
Note:
a Either G1, G2, or G3.
b Endocervical glandular involvement only should be considered as Stage I and no longer as Stage II.
c Positive cytology has to be reported separately without changing the stage.
Download
Click on the box below to download a PDF version of this data sheet:
Last edited: 21 December 2022 5:43 pm
- Cancer staging guidance sheets
- Lip and oral cavity (ICD10 C00, C02-C06)
- Malignant melanoma of upper aerodigestive tract (ICD10 C00-06, C10-14, C30-32)
- Pharynx (ICD10 C01, C05.1-2, C09, C10.0, C10.2-3, C11-13)
- Major salivary glands (ICD10 C07, C08)
- Oesophagus including oesophagastric junction (ICD10 C15 & C16.0)
- Stomach (ICD10 C16 except C16.0)
- Small intestine (ICD10 C17)
- Appendix (ICD10 C18.1)
- Colon and rectum (ICD10 C18-C20)
- Anal canal and perianal skin data (ICD10 C21, C44.5)
- Liver (ICD10 C22.0)
- Intrahepatic bile ducts (ICD10 C22.1)
- Gallbladder (ICD10 C23, C24.0)
- Distal extrahepatic bile duct (ICD10 C24.0)
- Perihilar bile ducts (ICD10 C24.0)
- Ampulla of vater (ICD10 C24.1)
- Pancreas (ICD10 C25)
- Nasal cavity and paranasal sinuses (ICD10 C30.0, C31.0, C31.1)
- Larynx (ICD10 C32.0 C32.1, C32.2, C10.1)
- Lung (ICD10 C34)
- Thymic tumours (ICD10 C37)
- Soft tissues (ICD10 C38.1-2, C47-C49)
- Bone (ICD10 C40 & C41)
- Malignant melanoma of skin (ICD10 C43, C51.0, C60.9, C63.2)
- Merkel cell carcinoma of skin (ICD10 C44 & C63.2)
- Skin carcinoma of the head and neck (ICD10 C44.0, C44.2-4)
- Carcinoma of skin of the eyelid (ICD10 C44.1)
- Carcinoma of skin (excluding eyelid, head and neck, perianal, vulva and penis) (ICD10 C44.5-7, C63.2)
- Pleural mesothelioma (ICD10 C45)
- Breast tumours (ICD10 C50)
- Vulva (ICD10 C51)
- Cervix uteri (ICD10 C53)
- Uterine sarcomas
- Uterus - endometrium (ICD10 C54.1, C55)
- Ovarian, fallopian tube and primary peritoneal carcinoma (ICD10 C56, C57, C48.1, C48.2)
- Gestational trophoblastic neoplasms (ICD10 C58)
- Penis tumours (ICD10 C60)
- Prostate tumours (ICD10 C61)
- Testis tumours (ICD10 C62)
- Kidney tumours (ICD10 C64)
- Renal pelvis and ureter tumours (ICD10 C65 & C66)
- Urinary bladder tumours (ICD10 C67)
- Urethra tumours (ICD10 C68.0)
- Carcinoma of conjuctiva (ICD10 C69.0)
- Malignant melanoma of conjuctiva (ICD10 C69.0)
- Retinoblastoma (ICD10 C69.2)
- Malignant melanoma of uvea (ICD10 C69.3, C69.4)
- Carcinoma of lacrimal gland (ICD10 C69.5)
- Sarcoma of orbit (ICD10 C69.6)
- Thyroid gland (ICD10 C73)
- Adrenal cortex (ICD10 C74.0)
- Chronic lymphocytic leukaemia
- Hepatoblastoma (CTYA)
- Hodgkins and non-hodgkins lymphoma (ICD10 C81-88)
- Medulloblastoma
- Multiple myeloma
- Neuroblastoma
- Neuroendocrine tumours of the foregut
- Neuroendocrine tumours of the midgut and hindgut
- Non-hodgkin lymphoma (children)
- Rhabdomyosarcoma and other soft tissue sarcomas (CTYA)
- Wilms tumour of the kidney